--(BUSINESS WIRE)--Abcuro ... at the American Academy of Neurology (AAN) Annual Meeting, taking place April 5-9, 2025, in San Diego, California. Ulviprubart is a first-in-class monoclonal antibody ...

Annual Meeting, taking place April 5-9, 2025, in San Diego, California. Ulviprubart is a first-in-class monoclonal antibody targeting killer cell lectin like receptor G1 (KLRG1), currently being ...

Recent FDA feedback received on SER-155 allogeneic hematopoietic stem cell transplant (allo-HSCT) next study provides support for the proposed ...

Ukrainian and Polish officials say U.S. arms deliveries to Ukraine have resumed. The deliveries came Wednesday, a day after the Trump administration lifted its suspension of military aid for Kyiv ...

LEO Pharma A/S, a global leader in medical dermatology, today presented late-breaking data showcasing responses in a subgroup ...

InflaRx N.V. (Nasdaq: IFRX), a biopharmaceutical company pioneering anti-inflammatory therapeutics targeting the complement system, today announced the presentation of multiple posters describing the ...

Recent FDA feedback received on SER-155 allogeneic hematopoietic stem cell transplant (allo-HSCT) next study provides support for the proposed primary efficacy endpoint of reduction in bloodstream inf ...

Q4 2024 Earnings Call Transcript March 11, 2025 Operator: Good afternoon, ladies and gentlemen, and welcome to the Zynex ...

Q4 2024 Earnings Call Transcript March 11, 2025 Zevra Therapeutics, Inc. misses on earnings expectations. Reported EPS is $-0 ...

--(BUSINESS WIRE)--Abcuro, Inc., a clinical-stage biotechnology ... at the American Academy of Neurology (AAN) Annual Meeting, taking place April 5-9, 2025, in San Diego, California. Ulviprubart is a ...

Business conferences, such as the ESTRO Congress (European Society for Radiotherapy and Oncology), will bring thousands of ...

Futurist Scott Steinberg’s take on the changing landscape of work, both for internal and external meeting environments, as ...